Kim R. Tsuchimoto

Insider Reports History

Entity
Individual
Location
C/O Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette, IL
Signature
/s/ Karthik Radhakrishnan ,Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim R. Tsuchimoto:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Chief Financial Officer, Director Restricted Stock Units 74.4K $54.4K $0.73 Jun 30, 2024 Direct
Monopar Therapeutics Chief Financial Officer, Director Common Stock 57.4K $42K $0.73 Jun 30, 2024 Direct

Insider Reports Filed by Kim R. Tsuchimoto

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNPR Monopar Therapeutics Jun 30, 2024 3 -$2.19K 4 Jul 2, 2024 Chief Financial Officer, Director
MNPR Monopar Therapeutics Mar 31, 2024 3 -$2.78K 4 Apr 2, 2024 Chief Financial Officer, Director
MNPR Monopar Therapeutics Dec 31, 2023 6 -$1.56K 4 Jan 3, 2024 Chief Financial Officer, Director
MNPR Monopar Therapeutics Sep 30, 2023 3 -$2.13K 4 Oct 3, 2023 Chief Financial Officer, Director
MNPR Monopar Therapeutics Jun 30, 2023 3 -$4.36K 4 Jul 3, 2023 Chief Financial Officer, Director
MNPR Monopar Therapeutics Mar 31, 2023 3 -$2.56K 4 Apr 4, 2023 Chief Financial Officer, Director
MNPR Monopar Therapeutics Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Financial Officer
MNPR Monopar Therapeutics Dec 31, 2022 6 -$6.09K 4 Jan 3, 2023 Chief Financial Officer
MNPR Monopar Therapeutics Sep 30, 2022 3 -$2.66K 4 Oct 3, 2022 Chief Financial Officer
MNPR Monopar Therapeutics Jun 30, 2022 3 -$7.09K 4 Jul 1, 2022 Chief Financial Officer
MNPR Monopar Therapeutics Mar 31, 2022 3 -$1.28K 4 Apr 1, 2022 Chief Financial Officer
MNPR Monopar Therapeutics Feb 2, 2022 2 $0 4 Feb 4, 2022 Chief Financial Officer
MNPR Monopar Therapeutics Jan 1, 2022 3 -$1.62K 4 Jan 4, 2022 Chief Financial Officer
MNPR Monopar Therapeutics Dec 31, 2021 3 -$1.61K 4 Jan 4, 2022 Chief Financial Officer
MNPR Monopar Therapeutics Sep 30, 2021 3 -$2.06K 4 Oct 1, 2021 Chief Financial Officer
MNPR Monopar Therapeutics Jun 30, 2021 3 -$4.85K 4 Jul 2, 2021 Chief Financial Officer